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Borrelia burgdorferi, a spirochete that causes Lyme disease,
naturally synthesizes the C-terminal domain of the A subunit
of DNA gyrase as an abundant 34-kDa DNA-binding protein
(5). A full-length GyrA protein that includes the GyrA Cterminal domain is also synthesized in the organism. GyrA and
GyrB comprise DNA gyrase, an A2B2 heterotetramer, which is
the only topoisomerase capable of introducing negative supercoiling into closed-circular DNA molecules (2, 3, 9, 20). The B.
burgdorferi GyrA C-terminal domain is encoded on a transcript
that initiates within gyrA and is translated in the identical
reading frame as full-length GyrA (5). We term the protein
Gac (GyrA C-terminal domain) because it is a separate product of a distinct genetic unit. The gac gene encodes Gac and
consists of the 3⬘ 939 nucleotides of the gyrA gene. Gac, which
has not yet been found in any organism outside of the Borrelia
genus, functions similarly to the Escherichia coli protein HU
(5).
To begin to understand the role of Gac in B. burgdorferi, we
disrupted synthesis of the protein by mutating nucleotides critical for its translation while maintaining the gyrA open reading
frame. These mutations were introduced along with a coumermycin A1 resistance (Cour) gyrB allele (gyrBr), which was the
only selectable marker available for genetic studies in B. burgdorferi (10, 13, 14). The gyrBr allele has been used for genetic
disruption by allelic exchange on the B. burgdorferi 26-kb circular plasmid (1, 16, 18). Insertional inactivation of gac was not
feasible because such a mutation would also disrupt gyrA and
the synthesis of full-length GyrA, which is presumably essential
in B. burgdorferi (12).
For introducing mutations in gac, plasmid pGACKO was
created by first subcloning partially overlapping PCR products
containing the mutations into pTAKO1 and pTAKO2 (Fig. 1A
and B). pTAKO1 was constructed by PCR amplifying an approximately 4-kb fragment encoding the 5⬘ 301 bp of dnaA, all
of gyrBr, and the 5⬘ 1,521 bp of gyrA from B. burgdorferi strain
B31-NGR, using primers dnaA 301R and gyrA 1521R/
GACKO (Table 1). B31-NGR was created by site-directed
mutagenesis of strain B31 and contains mutations in gyrB encoding Asn-102 to Asp, Gly-104 to Asp, and Arg-133 to Ile,

which confer high-level resistance to coumermycin A1 (D. S.
Samuels, B. J. Kimmel, D. C. Criswell, C. F. Garon, W. M.
Huang, and C. H. Eggers, unpublished data). The amplification product was adenylated and cloned into plasmid PCR
2.1-TOPO (Invitrogen) according to the manufacturer’s instructions, creating plasmid pTAKO1 (Fig. 1A). Primer gyrA
1521R/GACKO was a mutagenic primer that introduced silent
mutations into the Shine-Dalgarno sequence to decrease ribosome binding, mutated an ATG Met codon (position 499 of
GyrA) (which is predicted to be the translational start codon)
to a CTT Leu codon to prevent translation of Gac, and mutated an ATG Met codon (position 503 of GyrA) to an ATT Ile
codon to prevent translation from initiating downstream (Fig.
1C). The introduced mutations correspond to residues found
at the homologous sites in E. coli GyrA (15).
Plasmid pTAKO2 was constructed by PCR amplifying a
900-bp fragment encoding gac from B31-NGR, using primers
gyrA 1462F/GACKO and gyrA 2362R. Primer gyrA 1462F/
GACKO was a mutagenic primer that introduced the complementary mutations as described above for primer gyrA 1521R/
GACKO. The amplification product was purified, the 5⬘ ends
were adenylated, and the product was cloned as described
above, creating plasmid pTAKO2 (Fig. 1A). The mutagenic
plasmid for disrupting synthesis of Gac (pGACKO) was constructed by ligating the approximately 800-bp SpeI fragment
from plasmid pTAKO2 into the SpeI sites in plasmid pTAKO1
(Fig. 1B).
B. burgdorferi B31 was transformed with pGACKO and was
plated in solid medium containing 0.5 g of coumermycin A1
ml⫺1 as previously described (11). A successful recombination
event resulted from a double crossover or a single crossover
and branch migration spanning the mutations conferring coumarin resistance in the 5⬘ region of gyrB and the mutations in
the gac gene (approximately 4 kb). Cour transformants were
screened for gyrA mutations by PCR analysis with primers gyrA
1492F/GACKOSC and gyrA 2362R as previously described
(10). Primer gyrA 1492F/GACKOSC is complementary to the
mutated sequence, but only 15 of the 18 nucleotides in the
primer are complementary to the wild-type sequence, including a noncomplementary nucleotide at the 3⬘ end. These two
primers amplify a ⬃900-bp fragment from the mutated sequence, but they fail to amplify the same product from wildtype gyrA with a 56°C annealing temperature (data not shown).
Three of 400 Cour colonies contained the introduced mutations. The frequency of recombination was comparable to or
better than the directed insertion of gyrBr into cp26 (1, 10, 16,
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The C-terminal domain of the A subunit of DNA gyrase, which we term Gac, is naturally synthesized in
Borrelia burgdorferi as an abundant DNA-binding protein. Full-length GyrA, which includes the C-terminal
domain, is also synthesized by the spirochete and functions as a subunit of DNA gyrase. We have disrupted
synthesis of Gac as an independent protein and demonstrated that it is not essential for growth in a
coumarin-resistant background. We detected no alterations in DNA maintenance, condensation, or topology in
B. burgdorferi lacking this small DNA-binding protein.
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FIG. 1. Strategy for gac gene disruption. (A) Plasmid maps of pTAKO1 and
pTAKO2. Plasmid pTAKO1 contains the 5⬘ 301 bp of dnaA (dnaA1–301), all of
gyrBr (dnaA and gyrB are divergently expressed), and the 5⬘ 1,521 bp of gyrA
(gyrA1–1521). Plasmid pTAKO2 contains nucleotides 1492 to 2362 of gyrA
(gyrA1492–2362). SpeI (S) restriction sites are shown. Arrows indicate oligonucleotide primers used in site-directed mutagenesis and PCR analysis; numbers
below the arrows correspond to oligonucleotides listed in Table 1. Mutated sites
in gyrB from B31-NGR and introduced mutations in gyrA are indicated by shaded
boxes. (B) Plasmid map of pGACKO. The ⬃800-bp SpeI fragment of plasmid
pTAKO2 was cloned into the SpeI site of plasmid pTAKO1 to create plasmid
pGACKO. (C) Nucleotide and amino acid sequences of gyrA from strains B31,
B31-NGR, CKO-1, and CKO-2. Nucleotides 1474 to 1509 of gyrA, which encode
amino acids 492 to 503 of GyrA (and amino acids 1 to 5 of Gac) are shown.
Mutations are indicated with the corresponding amino acid change. Dots indicate nucleotide identity. Met 499 serves as the initiation codon for Gac, the
naturally synthesized GyrA C-terminal domain.

18). An increase in recombination efficiency may be due to the
need for only a single crossover, followed by branch migration,
rather than a double crossover event. However, the efficiency
remains low, possibly because of the large size of the fragment

required to recombine. The presence of mutations in two
clones, CKO-1 and CKO-2, was confirmed by DNA sequencing
(Fig. 1C). Clone CKO-1 contained all of the introduced mutations. Clone CKO-2 contained the mutations that changed
the two Met residues, but lacked the mutations in the ShineDalgarno sequence.
Western analysis confirmed that Gac synthesis was successfully disrupted in both clones (Fig. 2A and B). Whole-cell
lysates from B. burgdorferi strains B31 (wild type), B31-NGR,
CKO-1, and CKO-2 were analyzed by using an anti-Gac antiserum (5). The antiserum recognized the full-length 91-kDa
GyrA protein in all the whole-cell lysates, but it failed to detect
Gac in strains CKO-1 and CKO-2. B. burgdorferi B31-NGR is
isogenic to CKO-1 and CKO-2 with respect to the mutations in
gyrB. The successful disruption of Gac synthesis in CKO-2
indicates that the mutations in the Shine-Dalgarno sequence
were not critical for preventing translation.
The Gac-deficient strains grow in both liquid culture and
solid medium. They exhibit a growth rate and cellular morphology similar to B31 and B31-NGR (Fig. 3 and data not
shown). We have hypothesized that Gac may function in the
replication, compaction, and maintenance of linear replicons,
or in other aspects of linear DNA metabolism, in B. burgdorferi
(5). However, ethidium bromide staining of DNA extracts fractionated by agarose gel electrophoresis indicate that linear and
circular DNA molecules are maintained in CKO-1 and CKO-2
(Fig. 4). Gross DNA structure and morphology in strains

TABLE 1. Oligonucleotides used in this study
No.

Name

Sequence (5⬘-3⬘)a

1
2
3
4
5

dnaA 301R
gyrA 1521R/GACKO
gyrA 1462F/GACKO
gyrA 2362R
gyrA 1492F/GACKOSC

AAGTTTCGTTAAGAGCCG
ATTTTCTTTTTGAATTAAATCCGAAAGACTAGTTTTTAAAACTTCTTCATCATAAATTAT
ATAATTTATGATGAAGAAGTTTTAAAAACTAGTCTTTCGGATTTAATTCAAAAAGAAAAT
CTTTGCCTTGTTCAGATAC
AGTCTTTCGGATTTAATT

a

Mutagenic nucleotides are underlined.
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FIG. 2. Analysis of Gac synthesis in mutants by Western blotting. Whole-cell
B. burgdorferi lysates resolved by sodium dodecyl sulfate–12.5% polyacrylamide
gel electrophoresis and stained with Coomassie brilliant blue (panel A). Fractionated lysates were electroblotted to polyvinylidene difluoride and were probed
with an anti-Gac polyclonal antiserum (panel B) or an anti-Hbb polyclonal
antiserum (panel C). Molecular mass standards are shown on the left in kilodaltons.
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CKO-1 and CKO-2 is also unchanged, as examined by 4⬘,6diamidino-2-phenylindole (DAPI) staining (data not shown).
No differences in gene expression of the GyrA C-terminal
domain-deficient strains compared to strain B31-NGR were
detected by Coomassie brilliant blue-stained sodium dodecyl
sulfate-polyacrylamide gels of whole-cell lysates (Fig. 2A).
The absence of a distinguishable phenotype in the gac mutants suggested that the mutation may be suppressed by an
increase in expression of genes encoding other small DNAbinding proteins. We examined strains CKO-1 and CKO-2 for
an increase in expression of the hbb gene, which encodes Hbb,

FIG. 4. Effect of Gac on plasmid maintenance in B. burgdorferi. DNA isolated from B. burgdorferi strains B31, B31-NGR, CKO-1, and CKO-2 was analyzed by conventional 0.35% agarose gel electrophoresis (panel A) or fieldinversion 0.8% agarose gel electrophoresis (panel B) and was stained with
ethidium bromide.

the B. burgdorferi HU/IHF homolog (17). Whole-cell lysates
were examined by Western analysis using a polyclonal antiserum raised against a synthetic peptide (KRKGRLNARN
PQTGEA) designed with predicted antigenicity (MacVector;
Oxford Molecular). Hbb was present at low levels in all strains
examined, and its synthesis was unchanged in the gac mutants
(Fig. 2C), supporting previous biochemical evidence that Hbb
may play a limited role in B. burgdorferi DNA metabolism (5,
17).
The ability to disrupt synthesis of Gac demonstrates that the
protein is not essential. Based on the HU-like activity of the
protein (5), this finding is perhaps not surprising. E. coli strains
lacking both subunits of HU are viable (7). Major abnormalities of these E. coli strains include slow doubling times, poor
plasmid maintenance, and the inability to support bacteriophage Mu growth (4, 8, 19). Some of the observed phenotypes
of HU-deficient E. coli are unstable and are compensated by
the accumulation of suppressor mutations (4, 6). In E. coli,
mutations that map to gyrB (and confer resistance to the coumarin antibiotic novobiocin) suppress an HU deficiency (6).
The data presented here indicate that B. burgdorferi strains
lacking Gac do not exhibit any phenotypic differences in DNA
metabolism compared to isogenic strains. However, based on
the HU-like activity of this protein, the phenotype may be
suppressed by the presence of gyrBr, which confers resistance
to the coumarin antibiotic coumermycin A1.
We thank Kit Tilly, Karl Drlica, and Tasha Knight for thoughtful
and critical reading of the manuscript; Stuart Hill, Joe Hinnebusch,
and Tim Gsell for useful discussions; and the late Joan Strange for
DNA sequencing and peptide synthesis.
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FIG. 3. Effect of Gac on growth of B. burgdorferi. Growth was assayed essentially as described previously (12). Cultures of B. burgdorferi strains B31 (F), B31-NGR
(E), CKO-1 (‚), and CKO-2 () were inoculated with the same number of cells into BSK-H medium and were grown for 6 days. One milliliter of each culture was
removed each day, cells were pelleted and resuspended in 1 ml of Dulbecco’s phosphate-buffered saline, and the optical density at 600 nm was determined. Plotted
are the means of five independent experiments (four for days 4 and 6); error bars represent standard deviations.
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